WM TECHNOLOGY INC (MAPS)

US92971A1097 - Common Stock

1.48  +0.02 (+1.37%)

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to MAPS. MAPS was compared to 280 industry peers in the Software industry. MAPS has an excellent financial health rating, but there are some minor concerns on its profitability. MAPS has a valuation in line with the averages, but on the other hand it scores bad on growth.



4

1. Profitability

1.1 Basic Checks

MAPS had negative earnings in the past year.
MAPS had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: MAPS reported negative net income in multiple years.
The reported operating cash flow has been mixed in the past 5 years: MAPS reported negative operating cash flow in multiple years.

1.2 Ratios

With a Return On Assets value of -1.05%, MAPS perfoms like the industry average, outperforming 58.24% of the companies in the same industry.
Looking at the Return On Equity, with a value of -6.17%, MAPS is in line with its industry, outperforming 54.58% of the companies in the same industry.
With an excellent Return On Invested Capital value of 11.95%, MAPS belongs to the best of the industry, outperforming 88.28% of the companies in the same industry.
Industry RankSector Rank
ROA -1.05%
ROE -6.17%
ROIC 11.95%
ROA(3y)-15.89%
ROA(5y)-13.47%
ROE(3y)-277.04%
ROE(5y)-171.91%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

With an excellent Operating Margin value of 12.37%, MAPS belongs to the best of the industry, outperforming 80.59% of the companies in the same industry.
MAPS has a Gross Margin of 94.67%. This is amongst the best in the industry. MAPS outperforms 98.17% of its industry peers.
Industry RankSector Rank
OM 12.37%
PM (TTM) N/A
GM 94.67%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

7

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), MAPS is creating some value.
Compared to 1 year ago, MAPS has more shares outstanding
There is no outstanding debt for MAPS. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

An Altman-Z score of 2.12 indicates that MAPS is not a great score, but indicates only limited risk for bankruptcy at the moment.
MAPS has a Altman-Z score of 2.12. This is comparable to the rest of the industry: MAPS outperforms 44.32% of its industry peers.
MAPS has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 2.12
ROIC/WACC1.04
WACC11.53%

2.3 Liquidity

A Current Ratio of 2.14 indicates that MAPS has no problem at all paying its short term obligations.
MAPS has a Current ratio of 2.14. This is in the better half of the industry: MAPS outperforms 62.64% of its industry peers.
A Quick Ratio of 2.14 indicates that MAPS has no problem at all paying its short term obligations.
MAPS's Quick ratio of 2.14 is fine compared to the rest of the industry. MAPS outperforms 64.47% of its industry peers.
Industry RankSector Rank
Current Ratio 2.14
Quick Ratio 2.14

2

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 97.56% over the past year.
Looking at the last year, MAPS shows a decrease in Revenue. The Revenue has decreased by -9.00% in the last year.
EPS 1Y (TTM)97.56%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%250%
Revenue 1Y (TTM)-9%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-2.46%

3.2 Future

Based on estimates for the next years, MAPS will show a very strong growth in Earnings Per Share. The EPS will grow by 63.62% on average per year.
Based on estimates for the next years, MAPS will show a small growth in Revenue. The Revenue will grow by 5.94% on average per year.
EPS Next Y189.25%
EPS Next 2Y86.75%
EPS Next 3Y63.62%
EPS Next 5YN/A
Revenue Next Year-8.25%
Revenue Next 2Y0.05%
Revenue Next 3Y5.31%
Revenue Next 5Y5.94%

3.3 Evolution

6

4. Valuation

4.1 Price/Earnings Ratio

MAPS reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
MAPS is valuated reasonably with a Price/Forward Earnings ratio of 8.29.
Based on the Price/Forward Earnings ratio, MAPS is valued cheaper than 95.60% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.73, MAPS is valued rather cheaply.
Industry RankSector Rank
PE N/A
Fwd PE 8.29

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, MAPS is valued cheaply inside the industry as 96.34% of the companies are valued more expensively.
96.70% of the companies in the same industry are more expensive than MAPS, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 8.97
EV/EBITDA 6.86

4.3 Compensation for Growth

MAPS's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as MAPS's earnings are expected to grow with 63.62% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y86.75%
EPS Next 3Y63.62%

0

5. Dividend

5.1 Amount

No dividends for MAPS!.
Industry RankSector Rank
Dividend Yield N/A

WM TECHNOLOGY INC

NASDAQ:MAPS (1/6/2025, 3:59:50 PM)

1.48

+0.02 (+1.37%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)11-12 2024-11-12/amc
Earnings (Next)N/A N/A
Inst Owners43.03%
Inst Owner Change0%
Ins Owners16.08%
Ins Owner Change-8.79%
Market Cap226.77M
Analysts80
Price Target2.66 (79.73%)
Short Float %2.77%
Short Ratio1.83
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-26.47%
Min EPS beat(2)-50.98%
Max EPS beat(2)-1.96%
EPS beat(4)0
Avg EPS beat(4)-430.88%
Min EPS beat(4)-1668.63%
Max EPS beat(4)-1.96%
EPS beat(8)3
Avg EPS beat(8)-290.77%
EPS beat(12)5
Avg EPS beat(12)-78.91%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)3.67%
Min Revenue beat(2)2.68%
Max Revenue beat(2)4.66%
Revenue beat(4)2
Avg Revenue beat(4)-3.31%
Min Revenue beat(4)-13.64%
Max Revenue beat(4)4.66%
Revenue beat(8)5
Avg Revenue beat(8)-1.11%
Revenue beat(12)7
Avg Revenue beat(12)-1.16%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)33.5%
PT rev (3m)33.5%
EPS NQ rev (1m)0%
EPS NQ rev (3m)50%
EPS NY rev (1m)0%
EPS NY rev (3m)5%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.68%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 8.29
P/S 1.27
P/FCF 8.97
P/OCF 6
P/B 7.67
P/tB N/A
EV/EBITDA 6.86
EPS(TTM)-0.03
EYN/A
EPS(NY)0.18
Fwd EY12.06%
FCF(TTM)0.17
FCFY11.15%
OCF(TTM)0.25
OCFY16.67%
SpS1.16
BVpS0.19
TBVpS-0.27
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.05%
ROE -6.17%
ROCE 15.13%
ROIC 11.95%
ROICexc 17.29%
ROICexgc 57.53%
OM 12.37%
PM (TTM) N/A
GM 94.67%
FCFM 14.19%
ROA(3y)-15.89%
ROA(5y)-13.47%
ROE(3y)-277.04%
ROE(5y)-171.91%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover1.03
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 314.46%
Cap/Sales 7.01%
Interest Coverage 250
Cash Conversion 145.19%
Profit Quality N/A
Current Ratio 2.14
Quick Ratio 2.14
Altman-Z 2.12
F-Score6
WACC11.53%
ROIC/WACC1.04
Cap/Depr(3y)138.91%
Cap/Depr(5y)N/A
Cap/Sales(3y)5.96%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)97.56%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%250%
EPS Next Y189.25%
EPS Next 2Y86.75%
EPS Next 3Y63.62%
EPS Next 5YN/A
Revenue 1Y (TTM)-9%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-2.46%
Revenue Next Year-8.25%
Revenue Next 2Y0.05%
Revenue Next 3Y5.31%
Revenue Next 5Y5.94%
EBIT growth 1Y213%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year767.7%
EBIT Next 3Y111.81%
EBIT Next 5Y54.7%
FCF growth 1Y176.44%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y332.43%
OCF growth 3YN/A
OCF growth 5YN/A